Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients-Reference-Cited by-同舟云学术

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients

Published:2020-05-12 Issue:2 Volume:56 Page:2001526
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Yu Hai-qiong,Sun Bao-qing,Fang Zhang-fu,Zhao Jin-cun,Liu Xiao-yu,Li Yi-min,Sun Xi-zhuo,Liang Hong-feng,Zhong Bei,Huang Zhi-feng,Zheng Pei-yan,Tian Li-feng,Qu Hui-Qi^ORCID,Liu De-chen,Wang Er-yi,Xiao Xiao-jun,Li Shi-yue,Ye Feng,Guan Li,Hu Dong-sheng,Hakonarson Hakon,Liu Zhi-gang,Zhong Nan-shan

Funder

Zhejiang University special scientific research fund for COVID-19 prevention and control

Shenzhen Science and technology plan research project

Shenzhen Nanshan District Pioneer Group Research Funds

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2;Sanche;Emerging Infect Dis,2020

2. A novel coronavirus outbreak of global health concern

3. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection;Liu;JCI Insight,2019

4. Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7). http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.htm Date last accessed: 4 May 2020. Date last updated: 3 March 2020.

5. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine;Viruses;2024-01-26

2. Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial;Emerging Microbes & Infections;2023-12-30

3. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity;Scientific Reports;2023-12-09

4. Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort;Current Microbiology;2023-11-30

5. Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV;Vaccines;2023-11-24